Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegansKevin S. ChenKrystal Menezeset al.2021Molecular Neurodegeneration
Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's diseaseNaomi P. VisanjiPiyush Madanet al.2020Pharmacoepidemiology and Drug Safety
Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosisNadine BakkarTina Kovaliket al.2017Acta Neuropathologica